title: Double versus single autotransplantation in multiple myeloma; a single center experience of 100 patients.
abstract: One hundred patients with newly diagnosed multiple myeloma (MM) were treated with high-dose chemotherapy followed by single or double autologous stem cell transplantation (ASCT). Up-front treatment with a double ASCT tended to prolong progression-free and overall survival.
authors.forename: Mervi
authors.initials: M
authors.lastname: Putkonen
authors.forename: Auvo
authors.initials: A
authors.lastname: Rauhala
authors.forename: Maija
authors.initials: M
authors.lastname: Itälä
authors.forename: Marjut
authors.initials: M
authors.lastname: Kauppila
authors.forename: Tarja-Terttu
authors.initials: TT
authors.lastname: Pelliniemi
authors.forename: Kari
authors.initials: K
authors.lastname: Remes
mesh_terms: D000368:Aged; D006801:Humans; D009101:Multiple Myeloma / Q000601:surgery*; D016032:Randomized Controlled Trials as Topic; D033581:Stem Cell Transplantation / Q000379:methods*; D014182:Transplantation, Autologous